Catechol-O-methyltransferase genotype and dopamine regulation in the human brain

被引:0
|
作者
Akil, M [1 ]
Kolachana, BS [1 ]
Rothmond, DA [1 ]
Hyde, TM [1 ]
Weinberger, DR [1 ]
Kleinman, JE [1 ]
机构
[1] NIMH, Clin Brain Disorders Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA
来源
JOURNAL OF NEUROSCIENCE | 2003年 / 23卷 / 06期
关键词
catechol-O-methyltransferase; dopamine; tyrosine hydroxylase; human; genotype; midbrain; psychosis; schizophrenia;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A functional polymorphism in the gene for catechol-O-methyltransferase ( COMT) has been shown to affect executive cognition and the physiology of the prefrontal cortex in humans, probably by affecting prefrontal dopamine signaling. The COMT valine allele, associated with relatively poor prefrontal function, is also a gene that may increase risk for schizophrenia. Although poor performance on executive cognitive tasks and abnormal prefrontal function are characteristics of schizophrenia, so is psychosis, which has been related to excessive presynaptic dopamine activity in the striatum. Studies in animals have shown that diminished prefrontal dopamine neurotransmission leads to upregulation of striatal dopamine activity. We measured tyrosine hydroxylase (TH) mRNA in mesencephalic dopamine neurons in human brain and found that the COMT valine allele is also associated with increased TH gene expression, especially in neuronal populations that project to the striatum. This indicates that COMT genotype is a heritable aspect of dopamine regulation and it further explicates the mechanism by which the COMT valine allele increases susceptibility for psychosis.
引用
收藏
页码:2008 / 2013
页数:6
相关论文
共 50 条
  • [1] Catechol-O-methyltransferase, dopamine, and sleep-wake regulation
    Dauvilliers, Yves
    Tafti, Mehdi
    Landolt, Hans Peter
    [J]. SLEEP MEDICINE REVIEWS, 2015, 22 : 47 - 53
  • [2] Human catechol-O-methyltransferase down-regulation by estradiol
    Jiang, H
    Xie, T
    Ramsden, DB
    Ho, SL
    [J]. NEUROPHARMACOLOGY, 2003, 45 (07) : 1011 - 1018
  • [3] Regulation of dopamine-induced natriuresis by the dopamine-metabolizing enzyme catechol-O-methyltransferase
    Odlind, C
    Göransson, V
    Reenilä, I
    Hansell, P
    [J]. EXPERIMENTAL NEPHROLOGY, 1999, 7 (04): : 314 - 322
  • [4] O-METHYLATION OF DOPAMINE SULFATE WITH CATECHOL-O-METHYLTRANSFERASE
    OU, YQ
    HASHIMOTO, Y
    MIYAZAKI, H
    [J]. JOURNAL OF PHARMACOBIO-DYNAMICS, 1982, 5 (02): : S27 - S27
  • [5] Dopamine Effects on Human Error Processing Depend on Catechol-O-Methyltransferase VAL158MET Genotype
    Mueller, Erik M.
    Makeig, Scott
    Stemmler, Gerhard
    Hennig, Juergen
    Wacker, Jan
    [J]. JOURNAL OF NEUROSCIENCE, 2011, 31 (44): : 15818 - 15825
  • [6] CATECHOL-O-METHYLTRANSFERASE
    FLOHE, L
    [J]. INTERNATIONAL PHARMACOPSYCHIATRY, 1974, 9 (01): : 52 - 60
  • [7] CATECHOL-O-METHYLTRANSFERASE GENOTYPE, BUT NOT DOPAMINE RECEPTOR D2 GENOTYPE, MODULATES SLOW WAVE SLEEP
    Muck, Rachael
    Van Dongen, Hans
    Satterfield, Brieann
    [J]. SLEEP, 2023, 46 : A91 - A91
  • [8] Prefrontal electrophysiologic "noise" and catechol-O-methyltransferase genotype in schizophrenia
    Winterer, Georg
    Egan, Michael F.
    Kolachana, Bhaskar S.
    Goldberg, Terry E.
    Coppola, Richard
    Weinberger, Daniel R.
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 60 (06) : 578 - 584
  • [9] CATECHOL-O-METHYLTRANSFERASE IN HUMAN BREAST CANCERS
    ASSICOT, M
    CONTESSO, G
    BOHUON, C
    [J]. EUROPEAN JOURNAL OF CANCER, 1977, 13 (09) : 961 - 966
  • [10] HUMAN LIVER CATECHOL-O-METHYLTRANSFERASE PHARMACOGENETICS
    BOUDIKOVA, B
    SZUMLANSKI, C
    MAIDAK, B
    WEINSHILBOUM, R
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (04) : 381 - 389